Statistics for Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act.

Total visits

views
Evolving brand-name and generic drug competition may warrant a revision of the Hatch-Waxman Act. 282

Total visits per month

views
June 2024 1
July 2024 3
August 2024 0
September 2024 1
October 2024 0
November 2024 0
December 2024 0

File Visits

views
EvolvingBrand-HA 11-2011.pdf 510

Top country views

views
France 40
United Kingdom 39
United States 33
China 25
Germany 23
Canada 6
South Korea 6
Netherlands 4
Singapore 3
Russia 2
Taiwan 2
Switzerland 1
European Union 1
Italy 1
Laos 1
Ukraine 1

Top city views

views
Alexandria 16
Beijing 10
Göttingen 10
Kiez 5
Shenzhen 5
Washington 4
Boston 3
Changi 3
Sainte-thérèse 3
Barnaul 2
Boardman 2
Mount Laurel 2
Omemee 2
Seoul 2
Woodbridge 2
Austin 1
Boise 1
Carson City 1
Chapel Hill 1
Dallas 1
Durham 1
Kiev 1
Minneapolis 1
Moreno Valley 1
Munich 1
Nanjing 1
New York 1
Old Bridge 1
Ottawa 1
Overland Park 1
Qingdao 1
Raleigh 1
Seattle 1
Suzhou 1
Vientiane 1
Yulee 1
Zürich 1